“The Antiseptics and Disinfectants market is estimated to be valued at USD 17.75 billion in 2020”, says Visiongain

30 October 2019
Pharma

Antiseptics and Disinfectants Market Forecast 2020-2030: Forecasts and Analysis By Type (Alcohol And Aldehyde, Phenols And Derivatives, Biguanides And Amides, Quaternary Ammonium Compounds, Iodine Compounds And Others), End User (Domestic User, Institutional User)  and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Antiseptics and Disinfectants sector analysis.

According to the report published by Visiongain, the Antiseptics and Disinfectants market is estimated to be valued at USD 17.75 billion in 2020 and is expected to expand at a CAGR of 6.7% over the forecast period 2020-2030. High prevalence of Hospital-acquired Infections (HAIs), awareness about home hygiene and the need for disinfection, and increasing use of endoscope reprocesses and surgical units across the globe are anticipated to propel the product demand.

The efficacy of a disinfectant relies on its inherent biocidal behavior, the strength of the disinfectant, the interaction moment, the nature of the ground disinfected, the hardness of the water used to dilute the disinfectant, the quantity of organic components current on the ground, and the sort and number of microorganisms involved. The Environmental Protection Agency (EPA) registers chemical disinfectants marketed in the United States under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and requires manufacturers to provide product information on the use of dilution, the type of microorganisms killed, and the necessary contact time. Certain liquid chemical sterilizers intended for use on critical or semicritical medical devices are defined and regulated by the U.S. Food and Drug Administration (FDA).

 

Antiseptics and Disinfectants Market is witnessing Growth due to factors such as

The industry is evaluated in different areas, namely North America, Europe, Asia Pacific, Latin America and Middle East and Africa, based on geography. Europe represents the significant portion of the worldwide industry for antiseptics and disinfectants. The region is anticipated to experience development in Norway, Denmark, and other European nations due to increasing healthcare spending. Due to enhanced knowledge of pandemic diseases such as contracting flu and viral infections, there has been a significant increase in the national use of antiseptic and disinfectant in this region since the last century.

Due to the prevalent Ayurveda in this region, Asia Pacific is anticipated to experience the greatest CAGR during the forecast period. The increasing amount of the medical industry combined with the literacy level is pushing the antiseptic and disinfectant industry in this region, primarily in China, India, Indonesia, and Thailand. In addition, raising awareness of personal care and maintaining hygiene in China and India's emerging economies is expected in the near future to increase market growth in this region's antiseptics and disinfectants market. Due to the saturation of the red meat market in the U.S. and Mexico, North America is expected to experience moderate growth within the forecast period. Over the years, this is anticipated to adversely affect the antiseptic and disinfectant industry. However, supply for antiseptic and disinfectant has increased in recent years due to increased knowledge of antiseptic and disinfectant dietary advantages. Major U.S. businesses are increasing their vegetable manufacturing capacity to maintain up with the increasing pressure on the U.S. economy for overseas goods. This is anticipated to boost antiseptic and disinfectant market growth. Furthermore, elevated literacy rates combined with the growing amount of healthcare centers and business centers are probable to add to antiseptic and disinfectant market growth.

 

Shift in Trends

The worldwide antiseptic and disinfectant industry can be separated into healthcare suppliers, business customers, and national consumers in terms of end-users. The section of healthcare suppliers dominates the worldwide industry and is probable to remain dominant by the beginning of 2030 and achieve marginal market share. Increasing amount of surgeries are probable to increase the frequency of medical device use, increase the incidence of hospital-acquired infections, and rise per annual revenue on health care spending are few value-added characteristics expected to drive the antiseptic and disinfectant industry. Increasing amount of clinics in emerging economies has resulted in the sector holding a prominent proportion of the worldwide economy. Due to antiseptic & disinfectant effectiveness against most vegetative organisms and embedded viruses and mushrooms, the business user section of the antiseptic and disinfectant industry is probable to grow during the prediction era at a prominent CAGR.

In order of geography, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa can segment the worldwide antiseptic and disinfectant industry. North America dominated the worldwide industry, but by the beginning of 2030 market share is expected to be lost. The North American economy is motivated mainly by the quickly growing geriatric population and hospital admission, elevated clinical acceptance of surgical therapy, and rising incidence of infectious diseases among the U.S. population. In addition, there has been a growing habit of washing surgical instruments using disinfectants in the U.S. healthcare facilities, which is expected to boost the U.S. market segment of healthcare suppliers during the forecast period. During the forecast period, the antiseptic and disinfectant industry in Asia Pacific is expected to grow rapidly. Japan dominated Asia Pacific's antiseptic and disinfectant industry, while China's industry is expected to grow over the forecast period at a substantial CAGR.

Antiseptic is a chemical substance used in or on the ground tissue of the human body to destroy the pathogens and damaging microorganism. They operate primarily by dissolving cell membranes, denaturing proteins, and causing evaporation dehydration of cells. For example, chloroxylenol is a mostly active chlorinated phenolic antiseptic against gram-positive bacteria and is used for vaginal examination in the lubrication of cream. On the other side, disinfectants are chemicals used in or on the ground of items to destroy the pathogenic microorganism. The main course of intervention of disinfectants involves cell membrane disturbance and denaturation of cell proteins and enzymes. These chemical agents are very efficient against bacteria, mycobacteria, and viruses that are vegetative gram-positive and gram-negative. For example, Lysol a phenol compound is used as a general disinfectant for domestic or hospital use, such as floor disinfection, bathrooms, wash basins, organic waste such as sputum, feces, urine, etc. It was expected that the global market for antiseptics and disinfectants will see high growth over the forecast period due to an increasing percentage of hospitals and advanced health care facilities across the forecast period.

Moreover, the health club and fitness center's increasing rate is also anticipated to fuel the demand for antiseptics and disinfectants. In addition, the youthful generation's passionate involvement in precaution over influenza, bacterial and viral diseases is likely to boost requirement for antiseptics and disinfectants. However, advanced countries ' rigid governance and saturated demand are expected to hamper market growth.

 

Regional Market Analysis

Followed by Europe, North America resulted the antiseptics and disinfectants industry. It is anticipated that the growing amount of surgeries in North America and healthcare workers will fuel national supply. The demand can be further driven by essential product requirements in surgical procedures and study areas to decrease the danger of contamination and infection transmission. Moreover, growing instances of hospital-acquired infections may also increase requirement for alternatives, as physicians also make rigorous suggestions for the use of disinfectant alternatives. Over the forecast period, all of these variables could boost global market growth.

Due to increasing instances of hospital-acquired infections and disease instances such as food poisoning, cholera, and typhoid fever in this region, the Asia Pacific region is anticipated to show the highest CAGR during the forecast period. In addition, significant teams are also constantly striving to join the Asia-Pacific untapped regions. These variables are expected to bode well in the close future for the national industry.

 

Competition in the market

Increasing amount of clinics in emerging economies has resulted in the sector holding a prominent proportion of the worldwide economy. Due to antiseptic & disinfectant effectiveness against most vegetative organisms and embedded viruses and mushrooms, the business user section of the antiseptic and disinfectant industry is probable to grow during the prediction era at a prominent CAGR.

3 M; Reckitt Benckiser; STERIS plc; Kimberly-Clark Corporation; Bio-Cide International Inc.; Cardinal Health; Novartis AG; BD; and Johnson & Johnson are prominent industry competitors. Key participants are engaged in policies such as mergers and acquisitions and alliances to reinforce their business situation. For example, in June 2018, Johnson & Johnson announced Fortive Corporation's conditional bid to purchase its Ethicon, Inc. subsidiary, Advanced Sterilization Products (ASP). This will assist the firm to expand its sterilization brand range and will also assist to increase client reach worldwide.

Recent News

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

Read

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

Read

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

Read

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever